Tag:

Germany

Latest Headlines

Latest Headlines

Eisai 'speechless' after another Fycompa price smack-down from Germany

Germany's cost-effectiveness gatekeepers have delivered another blow to Eisai over the price of Fycompa. And the verdict, just the drugmaker's latest frustration over the epilepsy drug, has left it "speechless" and "dismayed."

German meat company invests $30M in plant for traceable heparin ingredients

After tainted Chinese heparin in 2008 led to dozens of deaths of dialysis patients in the U.S., global regulators started touting the need for heparin makers to be able to track back sources to ensure they were safe. German meat company T ö nnies saw an opportunity there, bought a German heparin API maker and started building a brand-new plant. That facility was dedicated this week and will start producing heparin intermediates this year.

Germany's Aenova buys North Carolina packaging operation

Germany's Aenova has been in expansion mode. It pumped up production capacity with its acquisition last year of contract manufacturer Haupt Pharma and has now bought a U.S. company to help it boost its packaging capabilities. 

UPDATED: Germany gives an initial 'no additional benefit' on Biogen Idec's Tecfidera

Biogen Idec's multiple sclerosis blockbuster Tecfidera for a second time has hit a roadblock in its effort to replicate in Europe the kind of runaway success it has had in the U.S. Germany's price watchdog IQWIG says it has found "no additional benefit" for the treatment compared to existing options, a preliminary decision that could deny it premium pricing there.

Germany first in Europe to test database for defeating counterfeits

Germany is implementing a system that allows the authenticity of drugs to be checked at the pharmacy level to protect against counterfeits.

Merck sells salt plant in Lehrte to Schüssler Novachem

Having already bought the land on which Merck KGaA's salt plant in Lehrte, Germany, sits, salt maker Schüssler Novachem has now bought the production and laboratory equipment from the German drugmaker.

With new hopes for German pricing, Novo Nordisk decides to roll out Tresiba there

Novo Nordisk has decided to play ball in Germany. The Danish drugmaker now plans to launch its brand-new diabetes drug Tresiba in that country, despite a notorious pricing policy that Novo feared would interfere with its success.

Germany says it is unclear whether Gilead's Sovaldi prevents liver cancer

Gilead Sciences has argued that its hep C blockbuster Sovaldi will save healthcare payers money by preventing transplants for patients who develop cancer. But now the U.S. drugmaker has run into the Germany's IQWiG, the toughest among Europe's drug price watchdogs, and it says the evidence for that claim is unclear.

Cost watchdogs demand efficacy data on new Bayer cancer drugs

German pharma giant Bayer got back-to-back bad news on two of its newest drugs, from two different countries, no less.

The color purple knocks back Novartis' Advair rival in Germany

GlaxoSmithKline's asthma behemoth Advair may be losing ground in Europe, but a legal win may stop some of the bleeding--at least in Germany. The British pharma giant has obtained a preliminary injunction there to stop Novartis' Sandoz from hawking its generic, AirFluSal Forspiro, thanks to the inhaler's purple color.